カテゴリー： QYResearch, 世界, 部品/材料

世界のブタヘパリンナトリウム市場インサイト及び予測（純度≥99％、純度≥99.5％）

◆英語タイトル：Global Porcine Heparin Sodium Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JLX02132）◆商品コード：QY22JLX02132
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：126
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、ブタヘパリンナトリウムのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にブタヘパリンナトリウムの世界市場のxxx％を占める「純度≥99％」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「注射液」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
ブタヘパリンナトリウムの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのブタヘパリンナトリウム市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ブタヘパリンナトリウムのグローバル主要企業には、Pfizer、Bioibérica、OPOCRIN、Aspen、Suanfarma、Kraeber & Co GmbH、Hepartex、Hepalink Pharmaceutical Group、Nanjing King-friend、Haike Group、Cisen Pharmaceutical、Qianhong Biopharma、Xinbai Pharmaceuticals、Yino Pharma、Deebio Pharmaceutical、Tianjin Chasesun Pharmaceutical、Haike Group、Sheelian Pharmaceutical、Erye Pharmaceutical、Wanbang Pharmaceutical、Qingdao Kangyuan Pharmaceutical、CSBIO、Dongcheng Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ブタヘパリンナトリウム市場は、種類と用途によって区分されます。世界のブタヘパリンナトリウム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
純度≥99％、純度≥99.5％

【用途別セグメント】
注射液、軟膏、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ブタヘパリンナトリウム製品概要
- 種類別市場（純度≥99％、純度≥99.5％）
- 用途別市場（注射液、軟膏、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のブタヘパリンナトリウム販売量予測2017-2028
- 世界のブタヘパリンナトリウム売上予測2017-2028
- ブタヘパリンナトリウムの地域別販売量
- ブタヘパリンナトリウムの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ブタヘパリンナトリウム販売量
- 主要メーカー別ブタヘパリンナトリウム売上
- 主要メーカー別ブタヘパリンナトリウム価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（純度≥99％、純度≥99.5％）
- ブタヘパリンナトリウムの種類別販売量
- ブタヘパリンナトリウムの種類別売上
- ブタヘパリンナトリウムの種類別価格
・用途別市場規模（注射液、軟膏、その他）
- ブタヘパリンナトリウムの用途別販売量
- ブタヘパリンナトリウムの用途別売上
- ブタヘパリンナトリウムの用途別価格
・北米市場
- 北米のブタヘパリンナトリウム市場規模（種類別、用途別）
- 主要国別のブタヘパリンナトリウム市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのブタヘパリンナトリウム市場規模（種類別、用途別）
- 主要国別のブタヘパリンナトリウム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のブタヘパリンナトリウム市場規模（種類別、用途別）
- 主要国別のブタヘパリンナトリウム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のブタヘパリンナトリウム市場規模（種類別、用途別）
- 主要国別のブタヘパリンナトリウム市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのブタヘパリンナトリウム市場規模（種類別、用途別）
- 主要国別のブタヘパリンナトリウム市場規模（トルコ、サウジアラビア）
・企業情報
Pfizer、Bioibérica、OPOCRIN、Aspen、Suanfarma、Kraeber & Co GmbH、Hepartex、Hepalink Pharmaceutical Group、Nanjing King-friend、Haike Group、Cisen Pharmaceutical、Qianhong Biopharma、Xinbai Pharmaceuticals、Yino Pharma、Deebio Pharmaceutical、Tianjin Chasesun Pharmaceutical、Haike Group、Sheelian Pharmaceutical、Erye Pharmaceutical、Wanbang Pharmaceutical、Qingdao Kangyuan Pharmaceutical、CSBIO、Dongcheng Pharmaceutical
・産業チェーン及び販売チャネル分析
- ブタヘパリンナトリウムの産業チェーン分析
- ブタヘパリンナトリウムの原材料
- ブタヘパリンナトリウムの生産プロセス
- ブタヘパリンナトリウムの販売及びマーケティング
- ブタヘパリンナトリウムの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ブタヘパリンナトリウムの産業動向
- ブタヘパリンナトリウムのマーケットドライバー
- ブタヘパリンナトリウムの課題
- ブタヘパリンナトリウムの阻害要因
・主な調査結果

Market Analysis and Insights: Global Porcine Heparin Sodium Market
Due to the COVID-19 pandemic, the global Porcine Heparin Sodium market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99% accounting for % of the Porcine Heparin Sodium global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Injection Solution segment is altered to an % CAGR throughout this forecast period.
China Porcine Heparin Sodium market size is valued at US$ million in 2021, while the US and Europe Porcine Heparin Sodium are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Porcine Heparin Sodium landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Porcine Heparin Sodium include Pfizer, Bioibérica, OPOCRIN, Aspen, Suanfarma, Kraeber & Co GmbH, Hepartex, Hepalink Pharmaceutical Group and Nanjing King-friend, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Porcine Heparin Sodium capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Porcine Heparin Sodium by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Porcine Heparin Sodium Scope and Segment
Porcine Heparin Sodium market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Porcine Heparin Sodium market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity ≥99%
Purity ≥99.5%
Segment by Application
Injection Solution
Ointment
Others
By Company
Pfizer
Bioibérica
OPOCRIN
Aspen
Suanfarma
Kraeber & Co GmbH
Hepartex
Hepalink Pharmaceutical Group
Nanjing King-friend
Haike Group
Cisen Pharmaceutical
Qianhong Biopharma
Xinbai Pharmaceuticals
Yino Pharma
Deebio Pharmaceutical
Tianjin Chasesun Pharmaceutical
Haike Group
Sheelian Pharmaceutical
Erye Pharmaceutical
Wanbang Pharmaceutical
Qingdao Kangyuan Pharmaceutical
CSBIO
Dongcheng Pharmaceutical
Production by Region
North America
Europe
China
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Porcine Heparin Sodium Product Introduction
1.2 Market by Type
1.2.1 Global Porcine Heparin Sodium Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ≥99%
1.2.3 Purity ≥99.5%
1.3 Market by Application
1.3.1 Global Porcine Heparin Sodium Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Injection Solution
1.3.3 Ointment
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Porcine Heparin Sodium Production
2.1 Global Porcine Heparin Sodium Production Capacity (2017-2028)
2.2 Global Porcine Heparin Sodium Production by Region: 2017 VS 2021 VS 2028
2.3 Global Porcine Heparin Sodium Production by Region
2.3.1 Global Porcine Heparin Sodium Historic Production by Region (2017-2022)
2.3.2 Global Porcine Heparin Sodium Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
3 Global Porcine Heparin Sodium Sales in Volume & Value Estimates and Forecasts
3.1 Global Porcine Heparin Sodium Sales Estimates and Forecasts 2017-2028
3.2 Global Porcine Heparin Sodium Revenue Estimates and Forecasts 2017-2028
3.3 Global Porcine Heparin Sodium Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Porcine Heparin Sodium Sales by Region
3.4.1 Global Porcine Heparin Sodium Sales by Region (2017-2022)
3.4.2 Global Sales Porcine Heparin Sodium by Region (2023-2028)
3.5 Global Porcine Heparin Sodium Revenue by Region
3.5.1 Global Porcine Heparin Sodium Revenue by Region (2017-2022)
3.5.2 Global Porcine Heparin Sodium Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Porcine Heparin Sodium Production Capacity by Manufacturers
4.2 Global Porcine Heparin Sodium Sales by Manufacturers
4.2.1 Global Porcine Heparin Sodium Sales by Manufacturers (2017-2022)
4.2.2 Global Porcine Heparin Sodium Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Porcine Heparin Sodium in 2021
4.3 Global Porcine Heparin Sodium Revenue by Manufacturers
4.3.1 Global Porcine Heparin Sodium Revenue by Manufacturers (2017-2022)
4.3.2 Global Porcine Heparin Sodium Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Porcine Heparin Sodium Revenue in 2021
4.4 Global Porcine Heparin Sodium Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Porcine Heparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Porcine Heparin Sodium Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Porcine Heparin Sodium Sales by Type
5.1.1 Global Porcine Heparin Sodium Historical Sales by Type (2017-2022)
5.1.2 Global Porcine Heparin Sodium Forecasted Sales by Type (2023-2028)
5.1.3 Global Porcine Heparin Sodium Sales Market Share by Type (2017-2028)
5.2 Global Porcine Heparin Sodium Revenue by Type
5.2.1 Global Porcine Heparin Sodium Historical Revenue by Type (2017-2022)
5.2.2 Global Porcine Heparin Sodium Forecasted Revenue by Type (2023-2028)
5.2.3 Global Porcine Heparin Sodium Revenue Market Share by Type (2017-2028)
5.3 Global Porcine Heparin Sodium Price by Type
5.3.1 Global Porcine Heparin Sodium Price by Type (2017-2022)
5.3.2 Global Porcine Heparin Sodium Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Porcine Heparin Sodium Sales by Application
6.1.1 Global Porcine Heparin Sodium Historical Sales by Application (2017-2022)
6.1.2 Global Porcine Heparin Sodium Forecasted Sales by Application (2023-2028)
6.1.3 Global Porcine Heparin Sodium Sales Market Share by Application (2017-2028)
6.2 Global Porcine Heparin Sodium Revenue by Application
6.2.1 Global Porcine Heparin Sodium Historical Revenue by Application (2017-2022)
6.2.2 Global Porcine Heparin Sodium Forecasted Revenue by Application (2023-2028)
6.2.3 Global Porcine Heparin Sodium Revenue Market Share by Application (2017-2028)
6.3 Global Porcine Heparin Sodium Price by Application
6.3.1 Global Porcine Heparin Sodium Price by Application (2017-2022)
6.3.2 Global Porcine Heparin Sodium Price Forecast by Application (2023-2028)
7 North America
7.1 North America Porcine Heparin Sodium Market Size by Type
7.1.1 North America Porcine Heparin Sodium Sales by Type (2017-2028)
7.1.2 North America Porcine Heparin Sodium Revenue by Type (2017-2028)
7.2 North America Porcine Heparin Sodium Market Size by Application
7.2.1 North America Porcine Heparin Sodium Sales by Application (2017-2028)
7.2.2 North America Porcine Heparin Sodium Revenue by Application (2017-2028)
7.3 North America Porcine Heparin Sodium Sales by Country
7.3.1 North America Porcine Heparin Sodium Sales by Country (2017-2028)
7.3.2 North America Porcine Heparin Sodium Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Porcine Heparin Sodium Market Size by Type
8.1.1 Europe Porcine Heparin Sodium Sales by Type (2017-2028)
8.1.2 Europe Porcine Heparin Sodium Revenue by Type (2017-2028)
8.2 Europe Porcine Heparin Sodium Market Size by Application
8.2.1 Europe Porcine Heparin Sodium Sales by Application (2017-2028)
8.2.2 Europe Porcine Heparin Sodium Revenue by Application (2017-2028)
8.3 Europe Porcine Heparin Sodium Sales by Country
8.3.1 Europe Porcine Heparin Sodium Sales by Country (2017-2028)
8.3.2 Europe Porcine Heparin Sodium Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Porcine Heparin Sodium Market Size by Type
9.1.1 Asia Pacific Porcine Heparin Sodium Sales by Type (2017-2028)
9.1.2 Asia Pacific Porcine Heparin Sodium Revenue by Type (2017-2028)
9.2 Asia Pacific Porcine Heparin Sodium Market Size by Application
9.2.1 Asia Pacific Porcine Heparin Sodium Sales by Application (2017-2028)
9.2.2 Asia Pacific Porcine Heparin Sodium Revenue by Application (2017-2028)
9.3 Asia Pacific Porcine Heparin Sodium Sales by Region
9.3.1 Asia Pacific Porcine Heparin Sodium Sales by Region (2017-2028)
9.3.2 Asia Pacific Porcine Heparin Sodium Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Porcine Heparin Sodium Market Size by Type
10.1.1 Latin America Porcine Heparin Sodium Sales by Type (2017-2028)
10.1.2 Latin America Porcine Heparin Sodium Revenue by Type (2017-2028)
10.2 Latin America Porcine Heparin Sodium Market Size by Application
10.2.1 Latin America Porcine Heparin Sodium Sales by Application (2017-2028)
10.2.2 Latin America Porcine Heparin Sodium Revenue by Application (2017-2028)
10.3 Latin America Porcine Heparin Sodium Sales by Country
10.3.1 Latin America Porcine Heparin Sodium Sales by Country (2017-2028)
10.3.2 Latin America Porcine Heparin Sodium Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Porcine Heparin Sodium Market Size by Type
11.1.1 Middle East and Africa Porcine Heparin Sodium Sales by Type (2017-2028)
11.1.2 Middle East and Africa Porcine Heparin Sodium Revenue by Type (2017-2028)
11.2 Middle East and Africa Porcine Heparin Sodium Market Size by Application
11.2.1 Middle East and Africa Porcine Heparin Sodium Sales by Application (2017-2028)
11.2.2 Middle East and Africa Porcine Heparin Sodium Revenue by Application (2017-2028)
11.3 Middle East and Africa Porcine Heparin Sodium Sales by Country
11.3.1 Middle East and Africa Porcine Heparin Sodium Sales by Country (2017-2028)
11.3.2 Middle East and Africa Porcine Heparin Sodium Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Overview
12.1.3 Pfizer Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Pfizer Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Pfizer Recent Developments
12.2 Bioibérica
12.2.1 Bioibérica Corporation Information
12.2.2 Bioibérica Overview
12.2.3 Bioibérica Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Bioibérica Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Bioibérica Recent Developments
12.3 OPOCRIN
12.3.1 OPOCRIN Corporation Information
12.3.2 OPOCRIN Overview
12.3.3 OPOCRIN Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 OPOCRIN Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 OPOCRIN Recent Developments
12.4 Aspen
12.4.1 Aspen Corporation Information
12.4.2 Aspen Overview
12.4.3 Aspen Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Aspen Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Aspen Recent Developments
12.5 Suanfarma
12.5.1 Suanfarma Corporation Information
12.5.2 Suanfarma Overview
12.5.3 Suanfarma Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Suanfarma Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Suanfarma Recent Developments
12.6 Kraeber & Co GmbH
12.6.1 Kraeber & Co GmbH Corporation Information
12.6.2 Kraeber & Co GmbH Overview
12.6.3 Kraeber & Co GmbH Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Kraeber & Co GmbH Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Kraeber & Co GmbH Recent Developments
12.7 Hepartex
12.7.1 Hepartex Corporation Information
12.7.2 Hepartex Overview
12.7.3 Hepartex Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Hepartex Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Hepartex Recent Developments
12.8 Hepalink Pharmaceutical Group
12.8.1 Hepalink Pharmaceutical Group Corporation Information
12.8.2 Hepalink Pharmaceutical Group Overview
12.8.3 Hepalink Pharmaceutical Group Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Hepalink Pharmaceutical Group Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Hepalink Pharmaceutical Group Recent Developments
12.9 Nanjing King-friend
12.9.1 Nanjing King-friend Corporation Information
12.9.2 Nanjing King-friend Overview
12.9.3 Nanjing King-friend Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Nanjing King-friend Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Nanjing King-friend Recent Developments
12.10 Haike Group
12.10.1 Haike Group Corporation Information
12.10.2 Haike Group Overview
12.10.3 Haike Group Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Haike Group Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Haike Group Recent Developments
12.11 Cisen Pharmaceutical
12.11.1 Cisen Pharmaceutical Corporation Information
12.11.2 Cisen Pharmaceutical Overview
12.11.3 Cisen Pharmaceutical Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Cisen Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Cisen Pharmaceutical Recent Developments
12.12 Qianhong Biopharma
12.12.1 Qianhong Biopharma Corporation Information
12.12.2 Qianhong Biopharma Overview
12.12.3 Qianhong Biopharma Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Qianhong Biopharma Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Qianhong Biopharma Recent Developments
12.13 Xinbai Pharmaceuticals
12.13.1 Xinbai Pharmaceuticals Corporation Information
12.13.2 Xinbai Pharmaceuticals Overview
12.13.3 Xinbai Pharmaceuticals Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Xinbai Pharmaceuticals Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Xinbai Pharmaceuticals Recent Developments
12.14 Yino Pharma
12.14.1 Yino Pharma Corporation Information
12.14.2 Yino Pharma Overview
12.14.3 Yino Pharma Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Yino Pharma Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Yino Pharma Recent Developments
12.15 Deebio Pharmaceutical
12.15.1 Deebio Pharmaceutical Corporation Information
12.15.2 Deebio Pharmaceutical Overview
12.15.3 Deebio Pharmaceutical Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Deebio Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Deebio Pharmaceutical Recent Developments
12.16 Tianjin Chasesun Pharmaceutical
12.16.1 Tianjin Chasesun Pharmaceutical Corporation Information
12.16.2 Tianjin Chasesun Pharmaceutical Overview
12.16.3 Tianjin Chasesun Pharmaceutical Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 Tianjin Chasesun Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Tianjin Chasesun Pharmaceutical Recent Developments
12.17 Haike Group
12.17.1 Haike Group Corporation Information
12.17.2 Haike Group Overview
12.17.3 Haike Group Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.17.4 Haike Group Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 Haike Group Recent Developments
12.18 Sheelian Pharmaceutical
12.18.1 Sheelian Pharmaceutical Corporation Information
12.18.2 Sheelian Pharmaceutical Overview
12.18.3 Sheelian Pharmaceutical Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.18.4 Sheelian Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.18.5 Sheelian Pharmaceutical Recent Developments
12.19 Erye Pharmaceutical
12.19.1 Erye Pharmaceutical Corporation Information
12.19.2 Erye Pharmaceutical Overview
12.19.3 Erye Pharmaceutical Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.19.4 Erye Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.19.5 Erye Pharmaceutical Recent Developments
12.20 Wanbang Pharmaceutical
12.20.1 Wanbang Pharmaceutical Corporation Information
12.20.2 Wanbang Pharmaceutical Overview
12.20.3 Wanbang Pharmaceutical Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.20.4 Wanbang Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.20.5 Wanbang Pharmaceutical Recent Developments
12.21 Qingdao Kangyuan Pharmaceutical
12.21.1 Qingdao Kangyuan Pharmaceutical Corporation Information
12.21.2 Qingdao Kangyuan Pharmaceutical Overview
12.21.3 Qingdao Kangyuan Pharmaceutical Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.21.4 Qingdao Kangyuan Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.21.5 Qingdao Kangyuan Pharmaceutical Recent Developments
12.22 CSBIO
12.22.1 CSBIO Corporation Information
12.22.2 CSBIO Overview
12.22.3 CSBIO Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.22.4 CSBIO Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.22.5 CSBIO Recent Developments
12.23 Dongcheng Pharmaceutical
12.23.1 Dongcheng Pharmaceutical Corporation Information
12.23.2 Dongcheng Pharmaceutical Overview
12.23.3 Dongcheng Pharmaceutical Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.23.4 Dongcheng Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.23.5 Dongcheng Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Porcine Heparin Sodium Industry Chain Analysis
13.2 Porcine Heparin Sodium Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Porcine Heparin Sodium Production Mode & Process
13.4 Porcine Heparin Sodium Sales and Marketing
13.4.1 Porcine Heparin Sodium Sales Channels
13.4.2 Porcine Heparin Sodium Distributors
13.5 Porcine Heparin Sodium Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Porcine Heparin Sodium Industry Trends
14.2 Porcine Heparin Sodium Market Drivers
14.3 Porcine Heparin Sodium Market Challenges
14.4 Porcine Heparin Sodium Market Restraints
15 Key Finding in The Global Porcine Heparin Sodium Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のブタヘパリンナトリウム市場インサイト及び予測（純度≥99％、純度≥99.5％）(Global Porcine Heparin Sodium Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ヘパリンナトリウムを含む羊の血液のグローバル市場予測2023-2029
  • ウシヘパリンのグローバル市場予測2023-2029
  • 世界のヘパリンカルシウムAPI市場インサイト及び予測（純度≥99％、純度≥99.5％）
  • 世界のクロモグリク酸ナトリウム原体市場インサイト及び予測（純度98%以上、純度99%以上）
  • 世界のダルテパリンナトリウムAPI市場インサイト及び予測（純度≥99％、純度≥99.5％）